Blocking the PD-1/PD-L1 pathway has been shown to restore the activity of exhausted virus-specific CD8 + T cells, resulting in regulated chronic HIV infection [44] and enhanced anti-cancer immunity [45]. Here, CD8A is linked to cancer.